Impact of adjuvant radiation therapy on survival and recurrence in stages I-III Merkel Cell Carcinoma: a retrospective study of 312 patients

Published: 9 May 2023| Version 1 | DOI: 10.17632/mgfk4npkr6.1
Contributors:
POTTIER CASSANDRE, Antoine Marchand, Thibault Kervarrec, Yannick Le Corre, Charlée Nardin, François Aubin, Ewa Wierzbicka-Hainaut, Julie Cassecuel, Brigitte Dreno, Guido Bens, Nathalie Beneton, Delphine Legoupil, Monica Dinulescu, Philippe Saiag, Astrid Fily-Blom, mahtab samimi

Description

Supplemental Figure 1. Panel A, Recurrence-free survival according to treatment. Panel B, local recurrence-free survival according to treatment. Panel C, in-transit recurrence-free survival according to treatment. Panel D, regional-lymph node recurrence-free survival according to treatment. Panel E, distant-metastasis free survival according to treatment. Supplemental Table I. Baseline treatment and patterns of recurrence, according to nodal status at baseline Supplemental Table II. Univariate and multivariate Cox proportional hazard analysis for MCC related death and MCC recurrence Supplemental Table III. Multivariate Cox proportional hazard analysis for local, in transit, regional recurrence and distant metastasis free survival Supplemental Table IV. Recurrence patterns after aRT on tumoral bed, according to nodal status at baseline Supplemental Table V. Recurrence patterns after aRT on LN area, according to nodal status at baseline

Files

Institutions

Universite de Tours

Categories

Radiation, Skin Cancer, Merkel Cell Carcinoma, Therapeutics, Adjuvant Therapy, Prognosis

Funding

La Ligue Contre le Cancer

Hopitaux Universitaires du Grand Ouest

Licence